Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-038619
Filing Date
2010-02-24
Accepted
2010-02-24 13:37:26
Documents
8
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 ISTA PHARMACEUTICALS FORM 10-K d10k.htm 10-K 1423779
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 14128
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex232.htm EX-23.2 14051
4 CERTIFICATION OF CEO - SECTION 302 dex311.htm EX-31.1 5992
5 CERTIFICATION OF CFO - SECTION 302 dex312.htm EX-31.2 6156
6 CERTIFICATION OF CEO - SECTION 906 dex321.htm EX-32.1 2456
7 CERTIFICATION OF CFO - SECTION 906 dex322.htm EX-32.2 2817
8 GRAPHIC g78240g35n99.jpg GRAPHIC 77960
  Complete submission text file 0001193125-10-038619.txt   1578437
Mailing Address 15295 ALTON PARKWAY IRVINE CA 92618
Business Address 15295 ALTON PARKWAY IRVINE CA 92618 949-788-6000
ISTA PHARMACEUTICALS INC (Filer) CIK: 0000930553 (see all company filings)

EIN.: 330511719 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31255 | Film No.: 10629129
SIC: 2835 In Vitro & In Vivo Diagnostic Substances